BiVACOR Welcomes New CEO and FDA Approval for TAH Device

AI-Powered Raspberry Pi Stethoscope Inno...

Advanced Technology Saves Patient's Life

Attune Medical's Growth in Esophageal Te...

Biospectal OptiBP: A Revolutionary Blood...

CARMAT's Advancements in Artificial Hear...

Fashion Designer's Health Update

BiVACOR appoints experienced medical device executive Jim Dillon as CEO and board member. The company's TAH device has received FDA approval for a clinical feasibility study.

Ask a question

Article Frequency

Coverage